معرفی
Petter Brodin is a dual-appointed academic with a Professorship at Karolinska Institutet's Department of Women's and Children's Health and a Senior Lecturer position at Imperial College London's MRC London Institute of Medical Sciences. His work bridges clinical pediatrics and cutting-edge systems immunology, focusing on human immune system profiling through blood analysis.
- Education: MD/PhD from Karolinska Institutet, postdoc at Stanford University
Research spans three major domains:
- Sex hormone immunomodulation - Revealing testosterone's role in suppressing autoimmune pathways while enhancing infection vulnerability through Nature studies of gender-affirming treatment
- Post-COVID pathophysiology - Developing antiviral treatment strategies for chronic SARS-CoV-2 reservoirs with Pfizer, focusing on severely affected patients
- Developmental immunology - Mapping immune-microbiome interactions in newborns and cancer immunotherapy applications in pediatric solid tumors
Major awards include:
- 2023 Oscar Medin Prize
- 2024 Wallenberg Scholar
- 2022 VR and SSMF Consolidator Awards
- 2019 EMBO Young Investigator
- 2015 ERC Starting Grant
Supervised 5 PhD/MSc students while leading a multidisciplinary team at BrodiN lab (brodinlab.com). Current clinical trials include:
- 15-day antiviral regimen for tissue reservoirs
- Immunomodulatory approaches for autoimmune profiles
Active in science communication through BlueSky platform and Paris Kids Cancer Symposium leadership, emphasizing human-centric research over animal models.
۰مقاله منتشرشده
